Stock PAVM PAVMED INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. PAVmed Inc.

Equities

PAVM

US70387R4039

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-03 pm EDT 		5-day change 1st Jan Change
2.07 USD -7.59% Intraday chart for PAVmed Inc. +20.35% -49.76%
Mar. 27 Transcript : PAVmed Inc., Q4 2023 Earnings Call, Mar 27, 2024
Mar. 25 PAVmed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cantor Fitzgerald Downgrades PAVmed to Neutral From Overweight, Cuts Price Target to $1.50 From $4
MT
Lake Street Adjusts PAVmed's Price Target to $1.50 From $5, Maintains Buy Rating
MT
Lake Street Trims Price Target on PAVmed to $5 From $7, Reiterates Buy Rating
MT
Cantor Fitzgerald Adjusts PAVmed's Price Target to $5 from $6, Keeps Overweight Rating
MT
PAVMED : Cantor Fitzgerald Starts PAVmed at Overweight With $8 Price Target
MT
PAVMED : Ascendiant Capital Starts PAVmed at Buy With $5 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PAVM Stock
  4. News PAVmed Inc.
  5. Analyst Reco.